Skip to content

Which antibiotic is most likely to cause Stevens-Johnson syndrome?

3 min read

According to a 2023 meta-analysis, antibiotics are associated with over one-quarter of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cases worldwide, with sulfonamides posing the highest risk. This serious drug hypersensitivity reaction requires immediate medical attention, and identifying which antibiotic is most likely to cause Stevens-Johnson syndrome is critical for patient safety.

Quick Summary

Sulfonamide antibiotics, including trimethoprim-sulfamethoxazole, are most strongly linked to Stevens-Johnson syndrome, though other classes like penicillins and cephalosporins also carry a notable risk.

Key Points

  • Sulfonamide antibiotics are the highest risk: Sulfonamide antibiotics, particularly trimethoprim-sulfamethoxazole, are most frequently associated with causing Stevens-Johnson syndrome.

  • Other classes carry notable risk: Beta-lactam antibiotics, including penicillins and cephalosporins, are also significant culprits for SJS, though less frequently than sulfonamides.

  • SJS is a T-cell mediated reaction: SJS is a serious, delayed immune reaction where the body's immune system mistakenly attacks skin and mucosal cells, leading to severe blistering and shedding.

  • Early symptoms are flu-like: The condition often begins with non-specific flu-like symptoms such as fever, headache, and body aches before the characteristic rash and blistering appear.

  • Immediate action is critical: If SJS is suspected, the implicated antibiotic must be stopped immediately, and emergency medical care should be sought without delay.

In This Article

Sulfonamide Antibiotics: The Highest Risk

Extensive research consistently points to sulfonamide antibiotics as the class most frequently implicated in Stevens-Johnson syndrome (SJS). A key culprit within this class is trimethoprim-sulfamethoxazole, also known as co-trimoxazole. A 2025 analysis of the FDA Adverse Event Reporting System (FAERS) specifically identified sulfamethoxazole as presenting the highest risk signal for SJS/TEN among various antibiotics. This heightened risk is a well-documented concern for clinicians and patients, underscoring the importance of judicious use for these medications, particularly for specific indications and durations.

Other High-Risk Antibiotic Classes

While sulfonamides lead the list, other antibiotic classes are also known to cause SJS, though typically with a lower frequency. The risk profile for antibiotic-induced SJS, in descending order of frequency, generally includes:

  • Penicillins: A major group of beta-lactam antibiotics, penicillins are frequently prescribed and are implicated in a significant portion of antibiotic-associated SJS cases. Examples include amoxicillin and amoxicillin-clavulanate.
  • Cephalosporins: Another beta-lactam class, cephalosporins also carry a notable risk for SJS. Specific examples linked to SJS/TEN cases include cefuroxime and ceftriaxone. There is also a rare but life-threatening risk of cross-reactivity with penicillins for severe reactions like SJS.
  • Fluoroquinolones: These broad-spectrum antibiotics have also been associated with SJS, though less commonly than sulfonamides and beta-lactams. Ciprofloxacin and levofloxacin are examples within this class.
  • Macrolides: Representing a smaller proportion of cases, macrolides like azithromycin have also been linked to SJS.

Understanding the Mechanism: How SJS Develops

SJS is categorized as a severe cutaneous adverse reaction (SCAR) and is a type IV, T-cell-mediated delayed hypersensitivity reaction. It isn't a simple allergy but a complex, delayed immune response. The trigger, in this case an antibiotic, prompts an overreaction from the body's immune system, leading to widespread cell death in the skin and mucous membranes. This reaction is not immediate and typically manifests within one to a few weeks of starting the medication. In many cases, genetic factors, specifically certain human leukocyte antigen (HLA) polymorphisms, can predispose individuals to this reaction when exposed to certain medications.

Comparison of Antibiotic Classes and SJS Risk

Antibiotic Class Examples Relative Risk Association (among antibiotics)
Sulfonamides Trimethoprim-sulfamethoxazole, Sulfasalazine Highest
Penicillins Amoxicillin, Amoxicillin-clavulanate High
Cephalosporins Cefuroxime, Ceftriaxone High
Fluoroquinolones Ciprofloxacin, Levofloxacin Moderate
Macrolides Azithromycin Lower

Recognizing the Symptoms of Stevens-Johnson Syndrome

Early recognition is crucial for improving outcomes. Symptoms often begin with a non-specific illness resembling an upper respiratory infection before the characteristic rash appears.

  • Initial symptoms: Fever, sore throat, headache, body aches, and fatigue.
  • Progressive symptoms: A flat, red or purplish rash that can spread quickly across the face, trunk, and limbs.
  • Blistering and skin detachment: The rash develops into painful blisters, and the epidermis begins to detach from the underlying dermis, often with lateral pressure (Nikolsky-positive sign).
  • Mucosal involvement: Painful blisters and erosions can affect the mucous membranes of the mouth, throat, eyes, and genitals. This can cause severe pain and complications like vision impairment or difficulty eating.

Immediate Action for Suspected SJS

If you or someone you know shows any signs of SJS, take these steps immediately:

  1. Stop the medication immediately: Do not take any more doses of the suspected drug.
  2. Seek emergency medical care: This is a medical emergency that requires prompt evaluation and treatment.
  3. Inform healthcare providers: Clearly state all medications you have recently taken so the culprit drug can be identified and avoided in the future.

Key Risk Factors Beyond Antibiotic Type

While the specific antibiotic class is the primary factor, other elements can increase an individual's susceptibility to antibiotic-induced SJS:

  • HIV/AIDS: Patients with HIV have a significantly higher risk of developing SJS compared to the general population.
  • Genetic predisposition: Certain HLA genetic markers can make some individuals more susceptible to drug-induced SJS.
  • Co-existing infections: Some infections, particularly certain viral or bacterial infections like Mycoplasma pneumoniae, can trigger SJS.
  • Underlying medical conditions: A history of systemic lupus erythematosus, psoriasis, or malignancy has been associated with an increased SJS risk.

Conclusion

While a variety of antibiotics can trigger Stevens-Johnson syndrome, the sulfonamide class, and especially the drug trimethoprim-sulfamethoxazole, is most consistently and strongly linked to the condition. Other significant culprits include penicillins and cephalosporins. Given the rarity but high morbidity and mortality of SJS, it is crucial for both healthcare providers and patients to be aware of the risk factors and early symptoms. Prompt discontinuation of the offending medication is the most important step for treatment, and awareness of the causative agents is vital for prevention based on information from a systematic review and meta-analysis published in JAMA Dermatology.

Frequently Asked Questions

Stevens-Johnson syndrome is a rare, severe, and potentially life-threatening mucocutaneous reaction, most often triggered by medications, that causes the painful blistering and shedding of skin and mucous membranes.

Among antibiotics, sulfonamide drugs pose the highest risk of causing SJS, with trimethoprim-sulfamethoxazole (co-trimoxazole) being a leading example.

SJS typically develops within one to a few weeks after starting the offending medication. Early symptoms can be non-specific, like a fever or sore throat, before the skin reaction begins.

SJS can also be triggered by a range of other medications, including certain anticonvulsants, allopurinol (for gout), and some nonsteroidal anti-inflammatory drugs (NSAIDs).

Yes, risk factors for antibiotic-induced SJS include HIV infection, certain genetic predispositions (HLA alleles), and underlying medical conditions such as systemic lupus erythematosus.

While it's considered prudent to be cautious, a past penicillin 'allergy' does not guarantee a cephalosporin reaction, and SJS is a different, more severe reaction than typical IgE-mediated allergies. However, some cases of cross-reactivity for severe reactions have been reported, and it is best to consult a healthcare provider.

If you notice a fever followed by a spreading, painful rash and blisters, immediately stop taking the medication and seek emergency medical care. Inform all healthcare providers about the medication you suspect triggered the reaction.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.